Suramin blocks interaction between human FGF1 and FGFR2 D2 domain and reduces downstream signaling activity.

scientific article

Suramin blocks interaction between human FGF1 and FGFR2 D2 domain and reduces downstream signaling activity. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BBRC.2016.06.149
P698PubMed publication ID27387234

P50authorRuey-Hwang ChouQ60566680
P2093author name stringChin Yu
Brian Fu
Zong-Sian Wu
Che Fu Liu
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectsuraminQ425946
P304page(s)861-867
P577publication date2016-07-04
P1433published inBiochemical and Biophysical Research CommunicationsQ864228
P1476titleSuramin blocks interaction between human FGF1 and FGFR2 D2 domain and reduces downstream signaling activity
P478volume477

Reverse relations

cites work (P2860)
Q95829467Cordycepin inhibits pancreatic cancer cell growth in vitro and in vivo via targeting FGFR2 and blocking ERK signaling
Q56833662New tools for carbohydrate sulfation analysis: heparan sulfate 2--sulfotransferase (HS2ST) is a target for small-molecule protein kinase inhibitors
Q92623870Single-cell RNA-seq identifies a reversible mesodermal activation in abnormally specified epithelia of p63 EEC syndrome
Q47148493Suramin increases cartilage proteoglycan accumulation in vitro and protects against joint damage triggered by papain injection in mouse knees in vivo.

Search more.